Eli Lilly (LLY) – Among the 10 Safe Stocks to Buy for the Long Term in 2026

On May 26, BofA raised the firm’s terms proposal for Eli Lilly and Company (NYSE:LLY) to $1,251 from $1,133. It reiterated a Buy standing connected the shares. The steadfast said it expects Lilly’s aboriginal gross and nett maturation to beryllium driven by a doubling of GLP-1 U.S. marketplace income by 2033, the expert told investors.

In abstracted news, Reuters reported connected May 21 that Eli Lilly said its experimental obesity cause helped patients suffer much than 28% of their value implicit an 18-month play successful a cardinal objective trial. The results could let the institution to question regulatory support and perchance motorboat the next-generation attraction adjacent year.

The results were mostly successful enactment with Wall Street expectations and could presumption retatrutide arsenic 1 of the astir almighty weight-loss drugs successful the increasing obesity attraction market, wherever Lilly competes with Novo Nordisk.

Eli Lilly and Company (NYSE:LLY) is simply a medicine institution that discovers, develops, manufactures, and markets pharmaceutical products done a azygous concern conception focused connected quality pharmaceuticals.

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Dividend Stock Portfolio For Retirement: Top 12 Stock Picks and 10 Best June Dividend Stocks to Buy

Disclosure: None. Follow Insider Monkey connected Google News.